skip to Main Content

Limited Edition Products and their IP Protection

Every renowned business has some products that they launch separately. They are launched either for a special occasion or simply the sale of first impression products. These products are named “Limited Editions”. These items have restricted production and remain in…

Zooming Out On Compulsory Licensing Of Covid-19 Vaccines

The unnerving bio- catastrophe, the COVID-19 pandemic has brought an array of challenges for mankind. The COVID-19 scare at the global level is posing threat to human life and the governments are deeply divided over an effort to endorse a…

Understanding the Relevance of Market Research for Patents

Significance of market research: An overview Understanding market trends and business environments play a crucial role in the development and successfulness of a particular product or service. More specifically, market research that is conducted before filing a patent or after…

Patent Searches- IIPRD’s Support Services

A patent ensures the protection of an invention for a limited period of time. Upon patenting an invention, a third party will be restricted from commercially exploiting or duplicating the invention in any manner. According to most patent laws around…

Analysing the Parliamentary Committee’s Recommendations on IPAB

The Central Government established the Intellectual Property Appellate Board (IPAB) on the 15th of September 2003. The Board was constituted exclusively for hearing appeals related to the registrar's decisions as per the Trade Marks Act, 1999, Geographical Indications of Goods…

DelSiTech and Visus Therapeutics enter into Patent Licensing Arrangement

Recently, DelSiTech Ltd. (“DelSiTech”), a Finland-based drug delivery company entered into a patent licensing agreement over DelSiTech’s patents with Visus Therapeutics (“Visius”), a US-based company. This is a worldwide exclusive licensing agreement. Both companies are working on six development programs…

Back To Top